Annual Cash & Cash Equivalents
$151.79 M
-$28.78 M-15.94%
30 June 2024
Summary:
Bio-Techne annual cash & cash equivalents is currently $151.79 million, with the most recent change of -$28.78 million (-15.94%) on 30 June 2024. During the last 3 years, it has fallen by -$47.30 million (-23.76%). TECH annual cash & cash equivalents is now -52.35% below its all-time high of $318.57 million, reached on 30 June 2014.TECH Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$187.54 M
+$35.75 M+23.55%
30 September 2024
Summary:
Bio-Techne quarterly cash and cash equivalents is currently $187.54 million, with the most recent change of +$35.75 million (+23.55%) on 30 September 2024. Over the past year, it has increased by +$38.88 million (+26.15%). TECH quarterly cash and cash equivalents is now -41.13% below its all-time high of $318.57 million, reached on 30 June 2014.TECH Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TECH Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.9% | +26.1% |
| 3 y3 years | -23.8% | -4.5% |
| 5 y5 years | +50.5% | +87.7% |
TECH Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -23.8% | at low | -11.5% | +47.3% |
| 5 y | 5 years | -23.8% | +50.5% | -11.5% | +87.7% |
| alltime | all time | -52.4% | >+9999.0% | -41.1% | >+9999.0% |
Bio-Techne Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $187.54 M(+23.6%) |
| June 2024 | $151.79 M(-15.9%) | $151.79 M(+8.5%) |
| Mar 2024 | - | $139.91 M(+7.5%) |
| Dec 2023 | - | $130.13 M(-12.5%) |
| Sept 2023 | - | $148.66 M(-17.7%) |
| June 2023 | $180.57 M(+4.6%) | $180.57 M(+41.9%) |
| Mar 2023 | - | $127.28 M(-22.7%) |
| Dec 2022 | - | $164.68 M(-0.3%) |
| Sept 2022 | - | $165.26 M(-4.2%) |
| June 2022 | $172.57 M(-13.3%) | $172.57 M(+7.3%) |
| Mar 2022 | - | $160.82 M(-24.1%) |
| Dec 2021 | - | $211.84 M(+7.9%) |
| Sept 2021 | - | $196.32 M(-1.4%) |
| June 2021 | $199.09 M(+35.8%) | $199.09 M(+7.0%) |
| Mar 2021 | - | $186.14 M(+12.5%) |
| Dec 2020 | - | $165.53 M(-2.3%) |
| Sept 2020 | - | $169.40 M(+15.5%) |
| June 2020 | $146.63 M(+45.3%) | $146.63 M(-6.1%) |
| Mar 2020 | - | $156.22 M(+41.6%) |
| Dec 2019 | - | $110.29 M(+10.4%) |
| Sept 2019 | - | $99.89 M(-1.0%) |
| June 2019 | $100.89 M(-17.3%) | $100.89 M(+5.6%) |
| Mar 2019 | - | $95.56 M(+11.3%) |
| Dec 2018 | - | $85.89 M(-9.3%) |
| Sept 2018 | - | $94.67 M(-22.4%) |
| June 2018 | $121.99 M(+33.2%) | $121.99 M(+40.9%) |
| Mar 2018 | - | $86.61 M(-28.7%) |
| Dec 2017 | - | $121.46 M(+67.6%) |
| Sept 2017 | - | $72.46 M(-20.9%) |
| June 2017 | $91.61 M(+42.6%) | $91.61 M(+53.1%) |
| Mar 2017 | - | $59.84 M(+1.5%) |
| Dec 2016 | - | $58.94 M(-15.3%) |
| Sept 2016 | - | $69.59 M(+8.3%) |
| June 2016 | $64.24 M(+17.8%) | $64.24 M(-2.2%) |
| Mar 2016 | - | $65.71 M(+5.2%) |
| Dec 2015 | - | $62.45 M(+27.9%) |
| Sept 2015 | - | $48.84 M(-10.4%) |
| June 2015 | $54.53 M(-82.9%) | $54.53 M(-48.8%) |
| Mar 2015 | - | $106.45 M(+14.5%) |
| Dec 2014 | - | $92.97 M(-5.4%) |
| Sept 2014 | - | $98.24 M(-69.2%) |
| June 2014 | $318.57 M(+94.5%) | $318.57 M(+157.7%) |
| Mar 2014 | - | $123.60 M(+25.6%) |
| Dec 2013 | - | $98.40 M(+17.3%) |
| Sept 2013 | - | $83.86 M(-48.8%) |
| June 2013 | $163.79 M(+40.4%) | $163.79 M(+8.7%) |
| Mar 2013 | - | $150.71 M(+5.2%) |
| Dec 2012 | - | $143.29 M(+9.5%) |
| Sept 2012 | - | $130.81 M(+12.1%) |
| June 2012 | $116.67 M(+50.3%) | $116.67 M(+22.5%) |
| Mar 2012 | - | $95.28 M(+17.6%) |
| Dec 2011 | - | $80.99 M(+2.2%) |
| Sept 2011 | - | $79.23 M(+2.1%) |
| June 2011 | $77.61 M(-17.6%) | $77.61 M(-51.1%) |
| Mar 2011 | - | $158.63 M(+16.7%) |
| Dec 2010 | - | $135.88 M(+18.1%) |
| Sept 2010 | - | $115.01 M(+22.2%) |
| June 2010 | $94.14 M(-41.5%) | $94.14 M(-13.0%) |
| Mar 2010 | - | $108.24 M(-44.7%) |
| Dec 2009 | - | $195.55 M(+11.9%) |
| Sept 2009 | - | $174.76 M(+8.6%) |
| June 2009 | $160.94 M(-3.6%) | $160.94 M(+20.3%) |
| Mar 2009 | - | $133.82 M(+11.9%) |
| Dec 2008 | - | $119.59 M(-26.2%) |
| Sept 2008 | - | $162.07 M(-2.9%) |
| June 2008 | $166.99 M(+23.3%) | $166.99 M(+2.5%) |
| Mar 2008 | - | $162.85 M(+9.5%) |
| Dec 2007 | - | $148.66 M(+2.7%) |
| Sept 2007 | - | $144.75 M(+6.8%) |
| June 2007 | $135.49 M | $135.49 M(+16.5%) |
| Mar 2007 | - | $116.28 M(+13.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | - | $102.56 M(+4.8%) |
| Sept 2006 | - | $97.83 M(+9.1%) |
| June 2006 | $89.63 M(+11.6%) | $89.63 M(+7.2%) |
| Mar 2006 | - | $83.60 M(+21.6%) |
| Dec 2005 | - | $68.73 M(-10.2%) |
| Sept 2005 | - | $76.52 M(-4.8%) |
| June 2005 | $80.34 M(+56.9%) | $80.34 M(+34.5%) |
| Mar 2005 | - | $59.75 M(-14.2%) |
| Dec 2004 | - | $69.63 M(+11.9%) |
| Sept 2004 | - | $62.24 M(+21.6%) |
| June 2004 | $51.20 M(+30.0%) | $51.20 M(-1.0%) |
| Mar 2004 | - | $51.73 M(+7.8%) |
| Dec 2003 | - | $47.97 M(+9.0%) |
| Sept 2003 | - | $44.02 M(+11.8%) |
| June 2003 | $39.37 M(+49.2%) | $39.37 M(+46.7%) |
| Mar 2003 | - | $26.84 M(-6.9%) |
| Dec 2002 | - | $28.82 M(-12.3%) |
| Sept 2002 | - | $32.88 M(+24.6%) |
| June 2002 | $26.39 M(+24.1%) | $26.39 M(+1.0%) |
| Mar 2002 | - | $26.14 M(-13.1%) |
| Dec 2001 | - | $30.08 M(+40.0%) |
| Sept 2001 | - | $21.48 M(+1.0%) |
| June 2001 | $21.27 M(+22.5%) | $21.27 M(+14.2%) |
| Mar 2001 | - | $18.62 M(+10.5%) |
| Dec 2000 | - | $16.86 M(-20.7%) |
| Sept 2000 | - | $21.26 M(+22.5%) |
| June 2000 | $17.36 M(+35.6%) | $17.36 M(-4.4%) |
| Mar 2000 | - | $18.16 M(-2.9%) |
| Dec 1999 | - | $18.70 M(+32.6%) |
| Sept 1999 | - | $14.10 M(+10.2%) |
| June 1999 | $12.80 M(-53.3%) | $12.80 M(+13.3%) |
| Mar 1999 | - | $11.30 M(-17.5%) |
| Dec 1998 | - | $13.70 M(+29.2%) |
| Sept 1998 | - | $10.60 M(-61.3%) |
| June 1998 | $27.40 M(+218.6%) | $27.40 M(+126.4%) |
| Mar 1998 | - | $12.10 M(+22.2%) |
| Dec 1997 | - | $9.90 M(+8.8%) |
| Sept 1997 | - | $9.10 M(+5.8%) |
| June 1997 | $8.60 M(+16.2%) | $8.60 M(+59.3%) |
| Mar 1997 | - | $5.40 M(-22.9%) |
| Dec 1996 | - | $7.00 M(+25.0%) |
| Sept 1996 | - | $5.60 M(-24.3%) |
| June 1996 | $7.40 M(+39.6%) | $7.40 M(+29.8%) |
| Mar 1996 | - | $5.70 M(+39.0%) |
| Dec 1995 | - | $4.10 M(-31.7%) |
| Sept 1995 | - | $6.00 M(+13.2%) |
| June 1995 | $5.30 M(-10.2%) | $5.30 M(+1.9%) |
| Mar 1995 | - | $5.20 M(+15.6%) |
| Dec 1994 | - | $4.50 M(-25.0%) |
| Sept 1994 | - | $6.00 M(+1.7%) |
| June 1994 | $5.90 M(+47.5%) | $5.90 M(+15.7%) |
| Mar 1994 | - | $5.10 M(+50.0%) |
| Dec 1993 | - | $3.40 M(0.0%) |
| Sept 1993 | - | $3.40 M(-15.0%) |
| June 1993 | $4.00 M(-11.1%) | $4.00 M(+60.0%) |
| Mar 1993 | - | $2.50 M(+19.0%) |
| Dec 1992 | - | $2.10 M(-16.0%) |
| Sept 1992 | - | $2.50 M(-44.4%) |
| June 1992 | $4.50 M(+125.0%) | $4.50 M(+15.4%) |
| Mar 1992 | - | $3.90 M(+77.3%) |
| Dec 1991 | - | $2.20 M(+22.2%) |
| Sept 1991 | - | $1.80 M(-10.0%) |
| June 1991 | $2.00 M(+53.8%) | $2.00 M(+33.3%) |
| Mar 1991 | - | $1.50 M(0.0%) |
| Dec 1990 | - | $1.50 M(-28.6%) |
| Sept 1990 | - | $2.10 M(+61.5%) |
| June 1990 | $1.30 M(+30.0%) | $1.30 M(-7.1%) |
| Mar 1990 | - | $1.40 M(+75.0%) |
| Dec 1989 | - | $800.00 K(-20.0%) |
| Sept 1989 | - | $1.00 M |
| June 1989 | $1.00 M | - |
FAQ
- What is Bio-Techne annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Bio-Techne?
- What is Bio-Techne annual cash & cash equivalents year-on-year change?
- What is Bio-Techne quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Bio-Techne?
- What is Bio-Techne quarterly cash and cash equivalents year-on-year change?
What is Bio-Techne annual cash & cash equivalents?
The current annual cash & cash equivalents of TECH is $151.79 M
What is the all time high annual cash & cash equivalents for Bio-Techne?
Bio-Techne all-time high annual cash & cash equivalents is $318.57 M
What is Bio-Techne annual cash & cash equivalents year-on-year change?
Over the past year, TECH annual cash & cash equivalents has changed by -$28.78 M (-15.94%)
What is Bio-Techne quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TECH is $187.54 M
What is the all time high quarterly cash and cash equivalents for Bio-Techne?
Bio-Techne all-time high quarterly cash and cash equivalents is $318.57 M
What is Bio-Techne quarterly cash and cash equivalents year-on-year change?
Over the past year, TECH quarterly cash and cash equivalents has changed by +$38.88 M (+26.15%)